Evidence map›Paper›PMID 24863067›Full record

ArticleThe Journal of experimental medicine2014

Regulation of mammalian siderophore 2,5-DHBA in the innate immune response to infection.

Zhuoming Liu, Scott Reba, Wei-Dong Chen, Suheel Kumar Porwal, W Henry Boom, Robert B Petersen, Roxana Rojas, Rajesh Viswanathan, L Devireddy

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Dopamine promotesFrontiers in cellular and infection microbiology · 2024
    Article
  6. Iron metabolism in colorectal cancer: a balancing act.Cellular oncology (Dordrecht, Netherlands) · 2023
    Review
  7. Article
  8. Review
  9. Review
  10. DMT1 Protects Macrophages fromInternational journal of molecular sciences · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Offense and Defense in Granulomatous Inflammation Disease.Frontiers in cellular and infection microbiology · 2022
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Frontiers in cell and developmental biology · 2021
    Article
  20. Biological Functions and Therapeutic Potential of Lipocalin 2 in Cancer.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Zhuoming LiuCase Comprehensive Cancer Center; Department of Pathology; Department of Medicine, Tuberculosis Research Institute and Division of Infectious Diseases; and Department of Chemistry, Case Western Reserve University, Cleveland, OH 44106Case Comprehensive Cancer Center; Department of Pathology; Department of Medicine, Tuberculosis Research Institute and Division of Infectious Diseases; and Department of Chemistry, Case Western Reserve University, Cleveland, OH 44106.
Scott RebaCase Comprehensive Cancer Center; Department of Pathology; Department of Medicine, Tuberculosis Research Institute and Division of Infectious Diseases; and Department of Chemistry, Case Western Reserve University, Cleveland, OH 44106.
Wei-Dong ChenGenetics Branch, National Cancer Institute/National Institutes of Health, Bethesda, MD 20892.
Suheel Kumar PorwalCase Comprehensive Cancer Center; Department of Pathology; Department of Medicine, Tuberculosis Research Institute and Division of Infectious Diseases; and Department of Chemistry, Case Western Reserve University, Cleveland, OH 44106Case Comprehensive Cancer Center; Department of Pathology; Department of Medicine, Tuberculosis Research Institute and Division of Infectious Diseases; and Department of Chemistry, Case Western Reserve University, Cleveland, OH 44106.
W Henry BoomCase Comprehensive Cancer Center; Department of Pathology; Department of Medicine, Tuberculosis Research Institute and Division of Infectious Diseases; and Department of Chemistry, Case Western Reserve University, Cleveland, OH 44106.
Robert B PetersenCase Comprehensive Cancer Center; Department of Pathology; Department of Medicine, Tuberculosis Research Institute and Division of Infectious Diseases; and Department of Chemistry, Case Western Reserve University, Cleveland, OH 44106.
Roxana RojasCase Comprehensive Cancer Center; Department of Pathology; Department of Medicine, Tuberculosis Research Institute and Division of Infectious Diseases; and Department of Chemistry, Case Western Reserve University, Cleveland, OH 44106.
Rajesh ViswanathanCase Comprehensive Cancer Center; Department of Pathology; Department of Medicine, Tuberculosis Research Institute and Division of Infectious Diseases; and Department of Chemistry, Case Western Reserve University, Cleveland, OH 44106.
L DevireddyCase Comprehensive Cancer Center; Department of Pathology; Department of Medicine, Tuberculosis Research Institute and Division of Infectious Diseases; and Department of Chemistry, Case Western Reserve University, Cleveland, OH 44106Case Comprehensive Cancer Center; Department of Pathology; Department of Medicine, Tuberculosis Research Institute and Division of Infectious Diseases; and Department of Chemistry, Case Western Reserve University, Cleveland, OH 44106 lxd59@case.edu.
Case Comprehensive Cancer CenterCase Western Reserve University · USNational Institutes of Health · US

Funding

HETEROGENEITY OF TCELLS IN M TUBERCULOSIS INFECTIONR01AI027243 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BOOM, W. HENRY · 1989 to 2016
$5.5M
Role of the Mammalian Siderophore in Cellular Iron Metabolism and ErythropoiesisR01DK081395 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI DEVIREDDY, LAXMINARAYANA R · 2008 to 2012
$1.7M
Role of TLR2 engagement on CD4+ T cells in immunity to M. tuberculosisR21AI099494 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI ROJAS, ROXANA E. · 2012 to 2013
$432k
NIAID NIH HHS R01 AI027243NIAID NIH HHS R21 AI099494NIDDK NIH HHS R01 DK081395NIDDK NIH HHS R01DK081395
6 · The paper itself

Abstract

Competition for iron influences host-pathogen interactions. Pathogens secrete small iron-binding moieties, siderophores, to acquire host iron. In response, the host secretes siderophore-binding proteins, such as lipocalin 24p3, which limit siderophore-mediated iron import into bacteria. Mammals produce 2,5-dihydroxy benzoic acid, a compound that resembles a bacterial siderophore. Our data suggest that bacteria use both mammalian and bacterial siderophores. In support of this idea, supplementation with mammalian siderophore enhances bacterial growth in vitro. In addition, mice lacking the mammalian siderophore resist E. coli infection. Finally, we show that the host responds to infection by suppressing siderophore synthesis while up-regulating lipocalin 24p3 expression via TLR signaling. Thus, reciprocal regulation of 24p3 and mammalian siderophore is a protective mechanism limiting microbial access to iron.

Indexed as

Acute-Phase ProteinsAnimalsBacterial InfectionsBacterial Outer Membrane ProteinsCandida albicansCandidiasisCarrier ProteinsCell LineEnterobactinEscherichia coliFemaleGentisatesHydroxybutyrate DehydrogenaseImmunity, InnateImmunoblottingKaplan-Meier Estimate2,5-dihydroxybenzoic acidAcute-Phase ProteinsBacterial Outer Membrane ProteinsCarrier ProteinsEnterobactinenterobactin receptorGentisatesHydroxybutyrate DehydrogenaseLcn2 protein, mouseLipocalin-2LipocalinsOncogene ProteinsPositive Regulatory Domain I-Binding Factor 1Prdm1 protein, mouseReceptors, Cell SurfaceSiderophoresTranscription Factors

Identifiers

PMID24863067
PMCPMC4042634
OpenAlexW2147688415

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.